Evidence map›Paper›PMID 40009125›Full record

ArticleImmunologic research2025

Concurrent infections in children with Kawasaki disease: lessons learned over 26 years.

Rakesh Kumar Pilania, Suprit Basu, Archan Sil, Sanjib Mondal, Abarna Thangaraj, Gayathri Cv, Manpreet Dhaliwal, Saniya Sharma, Ankur Kumar Jindal, Pandiarajan Vignesh and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rakesh Kumar PilaniaDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India. kumarpilania007@gmail.com.
Suprit BasuDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Archan SilDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sanjib MondalDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Abarna ThangarajDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Gayathri CvDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Manpreet DhaliwalDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Saniya SharmaDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Ankur Kumar JindalDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Pandiarajan VigneshDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sanjay VermaDepartment of Pediatrics, Pediatric Infectious Diseases Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Archana AngrupDepartment of Microbiology, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sanjeev H NaganurDepartment of Cardiology, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Manphool SinghalDepartment of Radiodiagnosis and Imaging, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Amit RawatDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Deepti SuriDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Surjit SinghDepartment of Pediatrics, Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, PGIMER, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Etiology of Kawasaki disease (KD) remains an enigma despite more than 50 years of extensive research. There is evidence that concurrent infections may play a role in the pathogenesis of KD. The present study reports various infections identified in a large cohort of patients with KD in Northwest India. We reviewed case records of patients with KD from January 1994 to February 2020. Patients with KD identified to have concurrent infection at presentation were analyzed in detail. Of 878 cases of KD during this period, 88 (60 boys, 28 girls; 64 incomplete KD, 24 complete KD) had evidence of concurrent infection. Infective manifestations included superficial and deep-seated abscesses (27.45%), pneumonia (28.4%), gastrointestinal manifestations (29.5%), urinary tract infection (4.5%), and septic arthritis (2.3%). Infectious agents were confirmed in 67/88 patients (76.13%) - these included bacteria (n = 51), viruses (n = 13), fungi (n = 2), and protozoa (n = 1). Among bacteria, infections with Staphylococcus sp. and Streptococcus sp. were the commonest (19/88 and 14/88 patients, respectively). Eighty-one children were treated with intravenous immunoglobulin (IVIg, 2 g/kg) and aspirin. Coronary artery abnormalities (CAAs) were seen in 11/88 patients (12.5%) during the acute phase - these normalized at 6 weeks of follow-up in all patients. To conclude, concurrent infections were seen in 10% of patients with KD at our center. If the clinical presentation suggests KD, one should not exclude the diagnosis even if there is evidence of an accompanying infection. Although 12.5% of patients with infection-associated KD had CAAs, none had persistent CAAs at 6 weeks of follow-up.

Indexed as

InfectionsMucocutaneous Lymph Node SyndromeChildChild, PreschoolFemaleHumansImmunoglobulins, IntravenousIndiaInfantMaleRetrospective StudiesImmunoglobulins, IntravenousBacterial infectionConcurrent infectionCoronary artery abnormalitiesIndiaKawasaki diseaseViral infection

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.